s.lundgren

TL2 · Kuopio

Contributes reviews on supplier material. Based in Kuopio.

Joined 23 December 2024 · last posted 7d

87 posts, newest first. Showing up to 150.

Selection into a registry and what it does to the estimate — a second dataset Replied, post #26 · Evidence › Study critique · 21 Jul 2026 · 17 likes Post #24 put the caveat in the right place and I want to underline it. Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by…
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #18 · Clinical › Bloodwork · 20 Jul 2026 · 10 likes The reason egfr fluctuation keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
Sleep quality changes during weight loss Replied, post #23 · Wellbeing › Sleep · 19 Jul 2026 · 0 likes Sleep hygiene: basics (cool dark room, consistent sleep time, no screens before bed) matter more during energy deficit because stress and sleep need are higher.
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #91 · Analytics › Impurities & related substances · 19 Jul 2026 · 0 likes Related substances: compounds chemically related to the target peptide but not the target peptide itself. The standard method separates them and reports them as area…
What changed in 2026, by region — does this still hold? Replied, post #23 · Access › International · 15 Jul 2026 · 2 likes A regional experience posted here should say which year it describes. The archive keeps these permanently and they age faster than anything else on the site.
Here for the analytics and not much else Replied, post #33 · Lounge › Introductions · 14 Jul 2026 · 0 likes Welcome. Nobody will mind you asking something basic. The people most likely to answer are the ones who remember not knowing it. Adding this to the thread rather than…
Request: a per-category review queue Replied, post #101 · Meta › Feature requests · 13 Jul 2026 · 29 likes Duplicate requests: if several people request the same feature, the requests often get merged. Check whether your feature has already been suggested before posting.
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #21 · Practice › Dosing & titration · 10 Jul 2026 · 0 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #4 · Compounds › Repair & healing peptides · 28 Jun 2026 · 30 likes The pentadecapeptide sequence is short and stable enough to survive conditions that would degrade a larger peptide, which is one of the few things about it that is well…
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #83 · Practice › Administration · 22 Jun 2026 · 0 likes Post #81 put the caveat in the right place and I want to underline it. Reporting rather than recommending, on Rotating between abdomen. What happened is above. Whether…
Carryover and the ghost peak from last week's standard — what changed since Replied, post #45 · Analytics › HPLC & UHPLC · 18 Jun 2026 · 31 likes Answering the question post #44 raises rather than the one it answers. Since Carryover keeps coming up, it should probably be a maintained page rather than a recurring…
[2026 update] Temperature indicator cards: worth asking for? Replied, post #6 · Sourcing › Logistics · 15 Jun 2026 · 21 likes Where I would push back on the Temperature indicator cards consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
A site rotation scheme that is easy enough to actually follow Replied, post #85 · Practice › Administration · 10 Jun 2026 · 4 likes Adding a data point of agreement rather than a data point.
Chain of custody for a sample you posted yourself — one year on Replied, post #23 · Sourcing › Independent verification · 8 Jun 2026 · 0 likes On Chain of custody, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #28 · Practice › Storage & stability · 31 May 2026 · 16 likes Mean kinetic temperature: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #71 · Compounds › Tirzepatide · 20 May 2026 · 0 likes A methods point on Tirzepatide and nausea rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in…
How much fluid is actually needed, and how you would know Replied, post #7 · Nutrition & Training › Hydration & electrolytes · 15 May 2026 · 30 likes Commercial rehydration formulations are designed for a specific purpose and are not equivalent to a sports drink, whatever the marketing suggests. Somebody will have a…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #63 · Data & Tools › Datasets · 10 May 2026 · 0 likes Taking post #62 at face value and following it one step further. The bit of community side-effect dataset that nobody enjoys is that the answer changes depending on…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #7 · Practice › Reconstitution · 11 Apr 2026 · 6 likes Post #4 is the version of this I will quote in future. One addition. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a…
Spike-and-recover accuracy for a peptide assay Replied, post #109 · Analytics › Method validation · 10 Apr 2026 · 2 likes I had written a reply contradicting post #105 and deleted it. Here is what survived. Stability-indicating method: one that can separate a compound from its degradation…
The anatomy of a question that gets answered within an hour Replied, post #14 · Start Here › How to Ask · 8 Apr 2026 · 15 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. Reporting the observation and leaving…
Validating a calculator against hand arithmetic Replied, post #16 · Data & Tools › Calculators · 6 Apr 2026 · 31 likes Reconstitution calculator: enter vial mass, final volume target, and the calculator tells you concentration and syringe mark for a given dose. Useful for…
Sample handling between despatch and injection Replied, post #21 · Analytics › Method validation · 6 Apr 2026 · 7 likes Small correction to my own earlier position on sample handling between despatch. I had the units the wrong way round, which changes the conclusion by an order of…
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #9 · Devices › Syringes & needles · 4 Apr 2026 · 11 likes 0.3 ml versus 0.5 ml has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #4 · Analytics › Home & field testing · 1 Apr 2026 · 2 likes The honest cost comparison is a home kit against a single independent submission. For most people the second answers the question and the first answers a different,…
[2026 update] Regional warehouse stock versus direct despatch Replied, post #30 · Sourcing › Logistics · 31 Mar 2026 · 8 likes Narrowing post #29, because the general version has more than one answer. For anyone finding this later: the short answer on Regional warehouse stock versus direct is…
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #25 · Compounds › Repair & healing peptides · 21 Mar 2026 · 3 likes This follows post #23 rather than contradicting it. The pentadecapeptide sequence is short and stable enough to survive conditions that would degrade a larger peptide,…
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #19 · Analytics › HPLC & UHPLC · 17 Mar 2026 · 1 like Worth separating two things that post #15 runs together. Summarising the Area percent versus weight percent thread so far, since it is long and the answer is buried:…
Reused chromatograms across lots: how to spot it — what changed since Replied, post #24 · Analytics › COA interpretation · 16 Mar 2026 · 1 like Reused chromatograms across lots would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
A single out-of-range value on an otherwise normal panel Replied, post #19 · Clinical › Bloodwork · 2 Mar 2026 · 0 likes Post #17 describes the usual case. This is about the unusual one. Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the…
Second pass at: What to keep a record of at the point of payment Replied, post #13 · Sourcing › Payments · 24 Feb 2026 · 0 likes Post #12 answers the question as asked. The question underneath it is different. Keeping a simple ledger of what was ordered, when, at what price, and what the…
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #89 · Outcomes › Progress reports · 19 Feb 2026 · 30 likes Post #86 is the version of this I will quote in future. One addition. If a pattern survives a rolling-mean treatment it is worth explaining. Most do not, and that is…
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #86 · Pharmacology › Pharmacokinetics · 18 Feb 2026 · 12 likes Summarising the Half-life thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the rest is…
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #2 · Compounds › Retatrutide · 17 Feb 2026 · 0 likes One more thing on TRIUMPH that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent…
Forced degradation studies: designing one that is informative Replied, post #5 · Analytics › Method validation · 10 Feb 2026 · 10 likes Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #5 · Analytics › Impurities & related substances · 8 Feb 2026 · 3 likes I read post #3 twice before replying, because I had assumed the opposite. Truncation products: fragments from incomplete synthesis or from degradation. They elute quite…
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #82 · Sourcing › Red flags · 8 Feb 2026 · 0 likes Summarising the supplier thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the rest is…
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #36 · Compounds › Retatrutide · 2 Feb 2026 · 0 likes This follows post #33 rather than contradicting it. Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not…
Heterogeneity as information rather than as a nuisance Replied, post #63 · Evidence › Meta-analyses · 15 Jan 2026 · 13 likes Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors are common and non-random. The right answer here…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #53 · Pharmacology › Receptor biology · 11 Jan 2026 · 18 likes Receptor distribution explains the side-effect profile better than anything else. GLP-1 receptors in the gastrointestinal tract and the area postrema account for most…
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #2 · Practice › Storage & stability · 2 Dec 2025 · 15 likes Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are red flags. Faint opalescence or minor colour shift may be normal but…
Managing an unplanned gap in supply — what changed since Replied, post #120 · Access › Shortages · 19 Nov 2025 · 0 likes Post #117 describes the usual case. This is about the unusual one. The claim about Managing an unplanned gap upthread is stronger than its source supports. I have read…
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #19 · Practice › Storage & stability · 5 Nov 2025 · 9 likes Post #17 is the version of this I will quote in future. One addition. The documentation on Storing lyophilised material long term is better than this thread and I say…
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #23 · Compounds › Semaglutide · 10 Oct 2025 · 9 likes Worth stating the null on semaglutide solutions before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.
The headache that turns out to be dehydration Replied, post #18 · Nutrition & Training › Hydration & electrolytes · 9 Oct 2025 · 0 likes Post #16 and I disagree about the size of the effect, not about the direction. Rapid correction of a genuine abnormality can be more dangerous than the abnormality,…
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #7 · Compounds › Retatrutide · 2 Oct 2025 · 7 likes Building on post #5 rather than restating it. Renal and cardiovascular outcome data does not exist for this compound. Absence of a reported signal in a phase 2 trial of…
Oral semaglutide bioavailability and its variability between people Replied, post #6 · Compounds › Oral incretins · 25 Sep 2025 · 4 likes Orforglipron is a small molecule rather than a peptide, which changes almost everything about how it is made, stored and analysed. Comparing it to oral semaglutide as…
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #55 · Practice › Dosing & titration · 22 Sep 2025 · 30 likes Post #52 answers the question as asked. The question underneath it is different. If symptoms reset at each step, that is the expected pattern rather than a sign that…
Follow-up: Why appetite effects are mostly central Replied, post #43 · Pharmacology › Receptor biology · 17 Sep 2025 · 1 like Adding the measurement that post #42 says would settle it. Species differences: rodent studies show the same compounds produce effects in rodents that predict human…
When a preprint is the best available evidence and we say so Replied, post #118 · Evidence › Preprints · 30 Aug 2025 · 12 likes Retractions and corrections do not propagate well from preprint servers. A citation that was fine when made can quietly become wrong.
Thyroid function tests during substantial weight change Replied, post #32 · Clinical › Bloodwork · 16 Aug 2025 · 0 likes Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most people realize. Comparing your result to the reference…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #11 · Evidence › Journal club · 10 Aug 2025 · 7 likes Worth separating two things that post #9 runs together. Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to…
Pinch or no pinch, and how needle length changes the answer Replied, post #8 · Practice › Administration · 3 Aug 2025 · 0 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.…
Why a pen's dose steps are fixed and what that costs you — one year on Replied, post #26 · Devices › Pens & autoinjectors · 24 Jul 2025 · 0 likes Priming exists because the needle and the cartridge path contain air after a needle change. Skipping it means the first fraction of the dose is not liquid. That holds…
Canadian access and provincial variation — one year on Replied, post #22 · Regional › North America · 23 Jul 2025 · 0 likes This follows post #21 rather than contradicting it. Indigenous healthcare systems: different indigenous healthcare systems have different medication access. Pathways…
Why the timeline is on the right and not the left Replied, post #29 · Meta › Site feedback · 15 Jun 2025 · 22 likes I came in to disagree and I am leaving without a disagreement.
Reading an MS report that only gives you a single number Replied, post #108 · Analytics › Mass spectrometry · 15 Jun 2025 · 0 likes Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge states. Reading an electrospray spectrum means…
[2026 update] An appeal that failed, and what I would do differently Replied, post #14 · Access › Insurance & coverage · 7 Jun 2025 · 1 like Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
[2026 update] Clearance pathways and what renal impairment changes Replied, post #28 · Pharmacology › Pharmacokinetics · 4 Jun 2025 · 11 likes Renal impairment changes clearance for some compounds in this class and not others, and the published data is compound-specific rather than class-wide. Adding a source…
Follow-up: What other technical communities get right that we do not Replied, post #110 · Lounge › Off topic · 26 May 2025 · 7 likes A digression that keeps occurring to me: the most-linked documents here are the dullest ones. Nothing gets cited like the unit-arithmetic page. The evidence for this is…
Shakes versus food: a pragmatic assessment — the long version Replied, post #36 · Nutrition & Training › Protein & intake · 26 May 2025 · 0 likes Taking post #33 at face value and following it one step further. My position on Shakes versus food is current rather than settled. I have revised it once already and I…
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #38 · Evidence › Trials · 26 May 2025 · 15 likes Coming back to post #36, because the follow-up matters more than the original answer. Marking my uncertainty on Comparators chosen for regulatory reasons explicitly. I…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #113 · Compounds › Cagrilintide & amylin analogues · 10 May 2025 · 2 likes The reason amylin analogue mechanism is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the…
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #39 · Practice › Reconstitution · 18 Apr 2025 · 10 likes That is a cleaner way of putting what I was circling around.
Scheduled maintenance and what will be unavailable Replied, post #108 · Meta › Announcements · 13 Apr 2025 · 22 likes Scheduled maintenance: if the site is going offline for maintenance, advance notice will be posted here with the duration and scope.
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #23 · Evidence › Journal club · 13 Apr 2025 · 8 likes The strongest argument against my own position on STEP 4, stated as well as I can state it, since nobody else has yet.
Talking to a therapist about this specifically — does this still hold? Replied, post #44 · Wellbeing › Mental health · 13 Apr 2025 · 1 like Confirming post #41 from a second method, which matters more than confirming it from a second person. Support and community: some people process weight change through…
Review cadence: how often is a page actually re-checked? Replied, post #17 · Documentation › Doc review · 12 Apr 2025 · 8 likes Worth separating two things that post #14 runs together. A review date is a commitment rather than a formality, and a shorter cycle for a fast-moving subject is the…
Coming back to: Oxidation and deamidation mass shifts, tabulated Replied, post #2 · Analytics › Mass spectrometry · 8 Apr 2025 · 8 likes Adding the measurement that the opening post says would settle it. Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #123 · Sourcing › Regulatory · 7 Apr 2025 · 3 likes Off-label use and medical practice: clinicians can prescribe approved medications off-label under some circumstances. That is different from research-use-only…
Anxiety in the first weeks: drug, situation, or both Replied, post #70 · Wellbeing › Mental health · 3 Apr 2025 · 19 likes Coming back to post #66, because the follow-up matters more than the original answer. On anxiety: the maintained page in the documentation commons covers the general…
Revisiting: Aggregate verification data across the directory, with caveats Replied, post #22 · Sourcing › Independent verification · 3 Mar 2025 · 21 likes The question underneath Aggregate verification data is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #28 · Sourcing › Regulatory · 28 Feb 2025 · 0 likes If you can confirm or contradict a position for your own region, please date the answer. An undated regional claim is the least useful thing in this category. The short…
SNAC and the mechanism of oral peptide absorption Replied, post #10 · Compounds › Oral incretins · 22 Feb 2025 · 0 likes Worth separating two things that post #8 runs together. PIONEER 6 is the cardiovascular outcome trial for oral semaglutide and it enrolled a diabetes population at high…
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #70 · Data & Tools › Calculators · 29 Jan 2025 · 24 likes Where a calculator and your own arithmetic disagree, the productive move is to find which step differs rather than to decide which is right.
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #22 · Analytics › COA interpretation · 18 Jan 2025 · 4 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #92 · Evidence › Journal club · 14 Jan 2025 · 0 likes Post #88 and I disagree about the size of the effect, not about the direction. A note on scope: what I am saying about SURPASS-2 applies to the case in the first post…
What changed in 2026, by region Replied, post #29 · Access › International · 19 Dec 2024 · 1 like Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide approved in the United States and European Union;…
Follow-up: Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #6 · Compounds › Semaglutide · 7 Dec 2024 · 3 likes On the injection-day question: the labelling for licensed semaglutide allows the day to be changed provided at least two days separate the two injections. That interval…
Time to steady state after a dose increase Replied, post #33 · Pharmacology › Pharmacokinetics · 3 Nov 2024 · 0 likes Loading doses are not used in this class and the pharmacokinetic reason is tolerability rather than efficacy. A loading dose would reach steady state faster and would…
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #18 · Clinical › Comorbidities · 4 Oct 2024 · 1 like Where I part company with post #16, and it is a narrow parting. Where two conditions pull in opposite directions, that is a clinical judgement rather than a lookup, and…
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #6 · Clinical › Comorbidities · 27 Sep 2024 · 15 likes Worth stating the null on Type 2 diabetes before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #47 · Practice › Administration · 22 Sep 2024 · 8 likes Injecting slowly is worth doing for volume rather than for chemistry. Larger volumes delivered quickly are the ones people report as uncomfortable. Speaking for myself…
Signs of dehydration worth acting on Replied, post #12 · Safety › Adverse events · 3 Sep 2024 · 26 likes The useful distinction on signs of dehydration worth acting is between what was measured and what was inferred from it. Both end up in the same sentence and only one of…
Chronic kidney disease and the FLOW result Replied, post #12 · Clinical › Comorbidities · 13 Aug 2024 · 3 likes Summarising the chronic kidney disease thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it,…
Second pass at: Journal club: LEADER as the historical anchor Replied, post #47 · Evidence › Journal club · 20 Jul 2024 · 14 likes The practical version of LEADER is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #45 · Practice › Dosing & titration · 8 Jul 2024 · 30 likes Post #44 answers the question as asked. The question underneath it is different. Speaking only to Splitting a weekly dose as I have actually seen it, rather than as it…